MedeliX
Start asking

Meloxicam

Meloxicam G.L., Movalis · ATC code M01AC06

Also known as: Meloksikam · Brand names: Meloxicam G.L., Movalis, Mobec, Enflar, Exen, Gramell, Loxidol, Meksun, Melbik, Melcam, Melox, Melurjin, Mone, Romacox, Runomex Fort …

Key facts
Active substance
Meloxicam
ATC code
M01AC06
Authorisation
authorised nationally; no central EU authorisation
Information as of
2026-10-27

Boxed warning

Cardiovascular Thrombotic Events

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use [ see Warnings and Precautions (5.1) ].
  • Meloxicam tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surgery [ see Contraindications (4)and Warnings and Precautions (5.1) ].

Gastrointestinal Bleeding, Ulceration, and Perforation

  • NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events [ see Warnings and Precautions (5.2) ].

Key facts

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID). It is used to relieve the signs and symptoms of osteoarthritis, rheumatoid arthritis and juvenile rheumatoid arthritis.

What it is used for

  • Osteoarthritis
  • Rheumatoid arthritis
  • Pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients weighing ≥60 kg

Dosing

  • Osteoarthritis and rheumatoid arthritis: 7.5 mg once daily; some patients may benefit from 15 mg once daily
  • Adults: maximum daily oral dose 15 mg
  • Juvenile rheumatoid arthritis: 7.5 mg once daily in children weighing ≥60 kg; not for children <60 kg
  • Hemodialysis: maximum 7.5 mg per day; not recommended in severe renal impairment
  • Lowest effective dose for the shortest duration; without regard to meals; not interchangeable with other oral meloxicam formulations

Contraindications

  • Known hypersensitivity to meloxicam or any component
  • History of asthma, urticaria or allergic-type reactions after aspirin or other NSAIDs
  • Setting of coronary artery bypass graft (CABG) surgery

Important warnings

  • Boxed warning: increased risk of serious, potentially fatal cardiovascular thrombotic events (MI, stroke)
  • Boxed warning: increased risk of serious GI bleeding, ulceration and perforation; higher in elderly and those with prior ulcer disease
  • Hepatotoxicity, hypertension, heart failure and edema
  • Renal toxicity and hyperkalemia
  • Anaphylactic reactions, serious skin reactions, DRESS

Side effects

  • Serious: cardiovascular thrombotic events, GI bleeding, hepatic and renal toxicity
  • Others: hypertension, edema, hematologic toxicity

Interactions

  • Anticoagulants such as warfarin: increased risk of serious bleeding
  • Drugs that interfere with serotonin reuptake: increased bleeding risk

Pregnancy and breastfeeding

  • NSAIDs can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios
  • Limit dose and duration between about 20 and 30 weeks of gestation; avoid at about 30 weeks and later

Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.

Full official text →

Common questions – ask Medelix

For patients

Patient information (US)

Patient information (US) →

Authorisation and brand names by country

Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.

Austria

  • Meloxicam G.L.G.L. Pharma Gmbh · 2 register entries
  • MovalisBoehringer Ingelheim Rcv Gmbh & Co Kg · 1 register entry

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Germany

  • Meloxicam1 A Pharma Gmbh, Stadapharm Gmbh, Aliud Pharma Gmbh · 3 register entries
  • MobecBoehringer Ingelheim Pharma Gmbh & Co. Kg · 1 register entry

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Turkey

  • EnflarASET İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
  • ExenSANOVEL İLAÇ SAN. VE TİC. A.Ş. · 5 register entries
  • GramellGMG GRAND MEDİCAL İLAÇLARI LTD. ŞTİ. · 1 register entry
  • LoxidolWORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş., WORLD MEDICINE OPHTHALMICS İLAÇLARI LTD. ŞTİ. · 4 register entries
  • MeksunBİOFARMA İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
  • MelbikULKAR İLAÇ PAZARLAMA LTD. ŞTİ. · 4 register entries
  • MelcamDEVA HOLDİNG A.Ş. · 4 register entries
  • MeloxNOBEL İLAÇ SAN. VE TİC. A.Ş. · 5 register entries
  • MelurjinDROGSAN İLAÇLARI SAN. VE TİC. A.Ş. · 4 register entries
  • MoneAPOTEX İLAÇ SAN VE TİC. LTD. ŞTİ. · 4 register entries
  • RomacoxALİ RAİF İLAÇ SAN. A.Ş. · 4 register entries
  • Runomex FortRECORDATİ İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
Show all 14 brand names
  • VeroxicamHAVER TRAKYA İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
  • ZeloximBİLİM İLAÇ SAN. VE TİC. A.Ş. · 5 register entries

Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16

USA

  • QamzovaNanjing Delova Biotech Co., Ltd. · 1 register entry
  • XifyrmAzurity Pharmaceuticals, Inc. · 1 register entry

Source: U.S. FDA – Drug labels (openFDA/DailyMed), as of 2026-10-28

Brand names in 25 more European countries
Belgium
Meloxicam Eg, Meloxicam Sandoz, Meloxicam Teva, Mobic
Bulgaria
Мелбек, Мелокс, Мелоксидин Булгермед Ве Еоод, Мелоксикам Дансон, Мовалис
Croatia
Meliam, Movalis
Cyprus
Melgesic, Melorem, Melox, Movatec, Oloxicam
Czechia
Melocox, Meloxicam Teva, Recoxa
Denmark
Meloxicam Stada, Meloxicam Teva
Estonia
Melox, Movalis, Recoxa
Finland
Mobic
France
Hexaphlogin, Meloxicam Biogaran, Meloxicam Eg, Meloxicam Teva, Meloxicam Zentiva, Mobic
Greece
Auroxicam, Brosiral, Farmelox, Iaten, Melice, Melocalm, Melock, Melocox, Meloprol, Melox, Meloxicam Kleva, Meloxicam/Kleva, Melus, Meomel, Mexilon, Movatec, Moxalid, Partial, Philipon-S, Reumotec®, Viclodex, Zerelin
Hungary
Camelox, Meloxan, Meloxep, Meloxicam Goodwill, Meloxicam Zentiva, Movalis, Noflamen
Ireland
Areloger
Italy
Meloxicam Eg, Meloxicam Mylan Generics, Meloxicam Zentiva, Mobic
Latvia
Melox, Mexolan, Movalis, Recoxa
Lithuania
Melobax, Melox, Mexolan, Movalis, Recoxa
Luxembourg
Meloxicam Eg, Mobic
Malta
Melox
Netherlands
Meloxicam Aurobindo, Meloxicam Unichem
Poland
Aglan, Aspicam, Difortan Tabs, Mel, Meloxicam Apteo Med, Moilec, Movalis, Opokan, Remolexam, Trosicam
Portugal
Meloxicam Almus, Meloxicam Azevedos, Meloxicam Basi, Meloxicam Beapy Bluemed Unipessoal Lda, Meloxicam Bluepharma, Meloxicam Ciclum, Meloxicam Generis, Meloxicam Gp, Meloxicam Lador, Meloxicam Ratiopharm, Meloxicam Tetrafarma, Meloxicam Vitória, Melpor, Movalis
Romania
Meloxicam Laropharm, Meloxicam Mcc, Meloxicam Rompharm, Meloxicam Vim Spectrum, Movalis
Slovakia
Meloxan, Meloxikam Fmk, Movalis
Slovenia
Movalis
Spain
Meloxicam Cinfa, Meloxicam Normon, Meloxicam Pensa, Meloxicam Stada, Movalis
Sweden
Melox

EMA – Article 57 product data (EU/EEA), 2026-10-28

Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.

Related calculators

Another question about this substance?

Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.

Sources

  1. U.S. Food and Drug Administration. Meloxicam (Chartwell RX, LLC) – Prescribing Information, 2025-12-17. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8bd53770-7077-49c7-8215-73a17a20ea70
  2. EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  3. EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  4. TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
  5. U.S. FDA – Drug labels (openFDA/DailyMed), 2026-10-28. https://dailymed.nlm.nih.gov/dailymed/

Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error

Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.